Temporal evolution of liver cancer etiology in China, 1990–2021: insights from the Global Burden of Disease Study 2021

The prevention and management of HBV infection in China have been efficient; however, the prevalence of metabolic illnesses in the etiology of liver cancer has escalated, and aging alongside population expansion has positively contributed to the increasing burden of liver cancer.